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Abstract
Background: Acute scaphoid fractures are common in active adults and do lead to reasonable
time lost to work. One important goal of treatment is early return to work or sport. On this
background, the adequate treatment of non-displaced acute scaphoid fractures is still under
discussion. The aim of this study is to compare time to return to previous activity level comparing
surgical versus non-surgical treatment of non-displaced acute scaphoid fractures.
Methods/Design:  The study is designed as a non-randomized multiple center cohort study
including 12 sites in Germany and Austria. The inclusion period is planned to be 12 months with a
follow up of 6 months. Allocation to operative or non-operative treatment is choosen by the
patient together with his treating surgeon. The primary outcome is time to return to previous
activity level adapted for loading of the wrist in daily life as measured by a newly developed
questionnaire (PLDL-wrist). Factors identified a priori to be associated with the outcome, e.g.,
poverty status, age, education, smoking status, gender, and occupation, are measured to ensure
adequate control for their potential confounding effects.
Discussion: The rationale and the design of a multiple center cohort study are presented. As it is
not considered feasible to randomize patients in this study, potential confounding effects need to
be controlled adequately.
Background
Acute scaphoid fractures mainly occur in active adults,
many of whom work as laborers or are involved in com-
petitive athletics; therefore, returning to work or sport is
an important goal of treatment. They are the most com-
mon fractures of the carpal bones. Time to union of acute
scaphoid fractures ranges from 6 to 18 weeks depending
on fracture type, localization of the fracture, degree of dis-
placement, and additional soft tissue injury [1-4].
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Cast immobilization remains the standard treatment
despite the fact that about 20% of fractures fail to heal
with conservative treatment[1,5,6]. It is well documented
that the rate of nonunion of acute scaphoid fractures is
higher for proximal and dislocated fracture types [7-10].
In displaced scaphoid fractures, the nonunion rate rises
up to 46%. Advances in the technique and in implants
developed for the operative fixation of acute scaphoid
fractures have made it technically easier with a higher rate
of union [5,11-16]. Operative treatment is recommended
for all displaced, unstable and complex fracture types
[2,5,13-15,17-20]. In non-displaced acute scaphoid frac-
tures treated by limited access and screw fixation the
union rate has been reported as high as 100% [4,5,11-
14,21].
The adequate treatment of non-displaced acute scaphoid
fractures is still under discussion. A few prospective stud-
ies with a limited number of patients and imprecise defi-
nitions of fracture type and union were published in 2000
and 2001 [11,12,16]. Despite favoring screw fixation, two
recent randomized controlled trials (RCTs) that used
'return to work' (RTW) as an outcome [12,22] did not pro-
vide a clear definition or did not define who determined
return to work. Neither study administered a patient-
derived quality of life measure specific to the wrist like the
Disability of the Arm, Shoulder and Hand (DASH) ques-
tionnaire [23-25]. In the Cochrane library, there are no
systematic reviews or meta-analyses on the treatment of
acute scaphoid fractures. Considering the problems asso-
ciated with prolonged cast immobilization, the complica-
tions of non-operative fracture treatment and social/
economic factors, it seems appropriate to evaluate the
possible advantages of routine operative treatment with a
less invasive screw fixation technique for non-displaced
acute scaphoid fractures.
The determination of RTW is of growing importance as an
outcome in clinical studies in the field of trauma and
orthopedic surgery and its application has increased in
recent years (Figure 1). One limitation of this outcome is,
however, that return to work is applicable for employees
only what implies, that RTW cannot be measured in e.g.,
students, housewifes and -men, unemployed or retired.
Also, a wide range of definitions of RTW can be found
throughout the literature. The different concepts of RTW
have been devided into three groups [26]: (1) Cumula-
tively, counting all days lost from work beginning with
the date of injury, (2) categorically, e.g., RTW ever (yes/
no); working at time × (yes/no) or (3) continuously, as
time-to-RTW. These concepts have in common, that no
information is given nor is any adjustment made for,
whether the physical load after RTW differs from the load
before the event observed. Therefore, no conclusions can
be drawn, whether any functional limitations after RTW
are present. To overcome the described limitations in the
context of this study, an additional instrument was
needed to adapt the outcome RTW and expand its mean-
ing to determine the physical load in daily life, including
work and household duties as well as leisure time.
We implemented a prospective cohort study to compare
patients with non-displaced scaphoid fractures undergo-
ing operative treatment with those who have non-opera-
tive care, addressing several questions: Is the time to
return to previous activity level different between those
undergoing surgery and those treated non-operatively? In
addition, it will be determined whether any differences in
treatment outcomes, including functional status as
derived from the DASH and SF-36 [27-31], complication
rate, range of motion, grip strength, and patient evalua-
tion of pain and overall satisfaction can be seen between
the patient groups. Such knowledge could support sur-
geons and patients in finding an adequate treatment deci-
sion.
Finally, cost-effectiveness of surgical versus non-surgical
treatment will be evaluated, focusing on direct, as well as
indirect costs of treatment and social/economic factors.
Number of publications of studies with RTW as outcome  parameter Figure 1
Number of publications of studies with RTW as out-
come parameter. Pubmed-search from 1966 – 12/2003 
using the search strategies: (1) [('return' OR 'day* lost' OR 
'disability') AND 'work'] OR 'sick leave'; Limit: 'Clinical Trial' 
(2) {[('return' OR 'day* lost' OR 'disability') AND 'work'] OR 
'sick leave'} AND 'Orthopaedic Procedures [mh]'. The 
abstracts of the retrieved publications were scanned to iden-
tify clinical studies using either 'return to work' or 'time of 
sick leave' as primary or secondary outcome. The found 
studies were categorised into one of the following 6 groups: 
'Hand', 'Spine', 'Long Bone', 'Foot and Ankle', 'Knee' or 'Neck 
and Shoulder'.BMC Musculoskeletal Disorders 2006, 7:41 http://www.biomedcentral.com/1471-2474/7/41
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Methods/Design
We designed a multi-center prospective cohort study of
patients with complete, non-displaced scaphoid fractures
receiving either operative or non-operative treatment to
compare the time to return to daily activities. The inclu-
sion period will be approximately 12 months. Follow-up
examinations (Figure 2) are planned at 6-weeks, 3-
months and 6-months following onset of treatment.
Additionally, telephone interviews are planned at 3-, 9-
and 15 weeks.
The clinical investigational plan was approved by the eth-
ics committee of the Medical Faculty of Philipps-Univer-
sity Marburg.
Study design
The study is designed as a non-randomized cohort study,
involving multiple sites with multiple surgeons and
potentially differing patient populations. The chosen
design implies a potential for bias and uncontrolled con-
founding. This will be addressed in the method of data
collection and data analysis (see below). The eligibility
Follow up procedures Figure 2
Follow up procedures. At 6-weeks, 3-months and 6-months, the determination of the outcomes is done during in-house vis-
its of the patients in the clinic. At 3-weeks, 9-weeks and 15-weeks, the QAS and PLDL-wrist questionnaires are retrieved via 
telephone interview.
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Table 1: Patient eligibility criteria
Inclusion criteria:
• Patient agreed with and signed the "informed consent" form
• Adult patients (≥ 18 years old) [Mature Skeleton]
• Patients with isolated, acute (no more than 2 weeks between injury and treatment), non-displaced complete fracture of the mid third of the 
scaphoid, without any dislocation or comminution visible on the CT scan (long axial 1-mm cuts, high resolution)
Exclusion criteria:
• Patients with acute fractures of both hands
• Patients with one hand missing
• All injuries other than isolated scaphoid fractures
• Patients with radiological signs of carpal instability
• Patients with signs of any rheumatoid, osteoarthritis or polyarthritis
• Patients with previous skeletal or severe soft tissue trauma to the same wrist
• History of drug or alcohol abuse
• General or local conditions adversely affecting bone physiology
• Patients unlikely to cooperate or attend all scheduled visits
• Patients who have participated in any other device or drug clinical trial within the previous month
• Patients with physical or mental incapacity, which makes it impossible to obtain informed consent
• Patients with legal incompetenceBMC Musculoskeletal Disorders 2006, 7:41 http://www.biomedcentral.com/1471-2474/7/41
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criteria do only allow patients to be included, that do have
isolated, complete fractures of the mid third of the
scaphoid without signs of displacement or comminution
visible in CT scan, while patients with any additional frac-
ture of other sites are excluded, leading to a very homoge-
nous injury pattern an thus minimizing residual
"confounding by indication".
Patients
Adult patients with isolated, acute (no more than 2 weeks
between injury and treatment) complete fracture of the
mid third of the scaphoid, without any signs of displace-
ment or comminution visible in CT scan, are eligible for
this study. Patients meeting the inclusion and exclusion
criteria (Table 1) are identified by the participating centers
and will be informed about the study. Patients are
recruited from 10 clinics in Germany and 2 clinics in Aus-
tria (Table 2). All patients need to sign an informed con-
sent form before entering the study.
Treatment allocation
The decision on whether to choose an operative or non-
operative treatment procedure is taken by the patient
together with his treating surgeon. The participation in the
study is completely independent of this decision and does
not influence the choice of treatment procedure. Patients
are classified as operative or non-operative according to
the initial treatment decision taken during the first two
weeks following injury.
Interventions
Operative treatment (Group A) will be performed using
minimally invasive palmar or dorsal access. Retrograde as
well as antegrade screw insertion is up to the choice of the
performing surgeon. The fracture fixation is done in free
hand technique, using a cannulated screw. Postoperative
splint immobilization should not exceed 1 week.
Non-operative treatment (Group B) will be performed
with short arm plaster cast including first carpo-metacar-
pal joint but leaving first metacarpal-phalangeal joint and
all fingers free. Immobilization for 6 weeks is recom-
mended, further immobilization if necessary.
Patients in both groups are supposed to receive 10 ses-
sions of physical therapy.
Outcome assessment
This study focuses on differences in time to return to daily
activities and patient derived quality of life instruments
between the two groups. These outcome parameters will
be assessed by means of questionnaires.
Primary outcome measures
(1) Questionnaire on physical loading of the wrist in daily
life (PLDL-wrist). The PLDL-wrist (Additional file 1: Ger-
man version, Additional file 2: English translation) is a
newly developed 17-item questionnaire, based on the
German translation of the DMQ [32]. Each of the items
can be answered by either 'YES' or 'NO', leading to a max-
imum score of 17. At baseline all patients will be inter-
viewed to get the baseline PLDL-score of the last week
before the injury. t0, being defined as the day of onset of
treatment, will be given the baseline PLDL-score. The
questionnaire will be repeated at several follow-ups
according to the schedule in Figure 2. The individual score
at every interview will be expressed as a percentage of the
baseline score (PLDLxweeks/PLDLBaseline * 100) and plotted
over time. The endpoint is defined as 'Time to reach the
individual 80%-threshold'. To determine the time point
at which the 80%-threshold is reached, the change
between the first score value exceeding the 80%-threshold
and the prior score value is linearized. The intercept of this
line and the 80%-threshold represents the linear estima-
tion of the first day of return to previous activity level (tre-
turn).
(2) Questionnaire on the activity status (QAS). The QAS
differentiates between the categories (A) return to work
[full; partly; no; not applicable], (B) return to household
duties [full, partly, no] and (C) return to leisure activities
[full, partly, no]. Using the QAS will allow us to include
Table 2: Participating clinics
• Klinik für Handchirurgie; Bad Neustadt, Germany
• Hand-, Replantations- und Mikrochirurgie; Unfallkrankenhaus Berlin-Marzahn, Germany
• HELIOS Klinikum, Unfall-, Hand- und Wiederherstellungschirurgie; Erfurt, Germany
• Hand- und Mikrochirurgie, Klinik für Unfallchirurgie; Justus-Liebig-Universität Giessen, Germany
• Universitätsklinik für Unfallchirurgie; Graz, Austria
• Klinik für Unfall- und Wiederherstellungschirurgie, Universitätsklinikum Eppendorf; Hamburg, Germany
• Universitätsklinik für Unfallchirurgie; Innsbruck, Austria
• Plastische und Handchirurgie, Universität Heidelberg, BG Unfallklinik; Ludwigshafen, Germany
• Universitätsklinik Marburg, Klinik für Unfall-, Wiederherstellungs- und Handchirurgie; Marburg, Germany
• Handchirurgie, TU München, Klinikum Rechts der Isar; München, Germany
• Unfall- und Wiederherstellungs-Chirurgie; Rosenheim, Germany
• Malteser Krankenhaus St. Josef, Klinik für Unfall- und Handchirurgie; Hamm, GermanyBMC Musculoskeletal Disorders 2006, 7:41 http://www.biomedcentral.com/1471-2474/7/41
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patients who are not formally employed (e.g. students,
housewives and -men, self- or unemployed). At baseline
all patients will be asked for their activity status in the last
week before the injury. This will be repeated according to
the schedule in Figure 2. A patient has returned to previ-
ous activity level either when he or she has returned to full
work and returned to full household duties or – for those
not being employed – has returned to full household
duties only. Rates of return to previous activity level will
be calculated for each of the follow-up periods. Leisure
activities are not included in this definition; these are eval-
uated as secondary outcomes, however.
Secondary outcome measures
(a) Disability of the Arm, Shoulder and Hand (DASH).
Functional status will be measured by the DASH question-
naire at every follow up (Figure 2.)
(b) Short Form 36 (SF-36). Quality of Life will be deter-
mined, using the SF-36 questionnaire according to the
schedule in Figure 2.
(c) Patient estimation of pain and patient satisfaction.
Overall satisfaction with the current condition will be
determined by the patient, using a visual analog scale
(VAS). Patients are asked to set a vertical mark on the VAS
for question 1: How would you estimate the pain in the
injured hand, ranging from 'No Pain' to 'Worst possible
Pain'?; and question 2: How would you estimate your sat-
isfaction with your current condition ranging from 'very
satisfying' to 'absolutely unacceptable'?
(d) Patient overall satisfaction with treatment will be
determined by the patient, using a 6-step scale ranging
from 'very good' to 'non-satisfactory'.
(e) Range of Motion (ROM) of the wrist will be measured
with a goniometer at all follow-up examinations by an
independent investigator.
(f) Grip strength will be measured with a Jamar
dynamometer, comparing the injured to the non-injured




Those patients suffering an acute complete fracture of the
mid third of the scaphoid bone without any dislocation or
comminution visible on the CT-scan who are treated sur-
gically with cannulated screw fixation will return to their
previous activity level sooner than patients treated non-
operatively with short arm cast immobilization.
Null hypothesis
There will be no difference in terms of return to previous
activity level between patients suffering an acute complete
fracture of the mid third of the scaphoid bone, without
any dislocation or comminution visible on the CT-scan
who are treated surgically with cannulated screw fixation
and patients treated non-operatively with short arm cast
immobilization.
Table 3: Sample size calculation for the primary outcome (2). The table contains specified accrual and dropout rates for 6 periods. 
This estimate of power was based on 1000 simulations of the study with a starting value for the random number generator of 678.
End of period, time t 0 3 6 9 12 15 24
A c c r u a l  ( %  o f  t o t a l ) 1 0 0 000000
Group A exponential hazard rate 0 0.0744 0.1567 0.3054 0.0959 0.3662 0.1018
Group B exponential hazard rate 0 0.0171 0.018 0.1959 0.0744 0.231 0.154
Group A SCREW expected % surviving 
time t
1 0 0 8 05 02 01 5 5 2
Group B CAST expected % surviving 
time t
1 0 0 9 59 05 04 02 0 5
Common exponential dropout rate 0 0.0034 0.0085 0.0117 0.0107 0.0108 0.0012
Time t 3 6 9 12 15 24
Follow up rate (similar in both groups) 0.99 0.95 0.90 0.88 0.85 0.75
Median survival 206.903 81.08 59.209 65.067 63.975 57.826
Exponential parameter 0.0034 0.0085 0.0117 0.0107 0.0108 0.012
Test significance level 0.05
Power (%) 92
Number needed Group A: 86
Number needed Group B: 30BMC Musculoskeletal Disorders 2006, 7:41 http://www.biomedcentral.com/1471-2474/7/41
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Sample size calculation
Given what was reported in 2 recent RCTs, it is anticipated
that we will detect a significant difference in mean time to
return to previous activity level comparing the two
groups. However, the primary outcome in these RCTs was
return to work, defined as 'time on sick leave' [22] and
'return to full military duty' [12], respectively; who deter-
mined the outcome was not defined, nor was the level of
posttraumatic physical activity compared with the level
prior to the trauma. The 'return to previous activity level'
is assumed to be equivalent to the definition of RTW
found in the 2 RCTs, but more objective.
According to a survey in the clinics being invited to partic-
ipate, it can be expected that the odds of patients receiving
non operative treatment in relation to those receiving sur-
gery is 1:4 (i.e. there will be 1 patient with short arm cast
treatment for each group of 4 patients being operated on).
The sample size calculation for the primary outcome (1)
is based on a two-sided two-sample t-test, a significance
level of 0.05 and a power of 90%. A difference of 4 weeks
between the two groups is likely and a standard deviation
of 5 weeks is anticipated. As a 25% loss to follow-up is
expected, we recommend a minimum of 112 patients in
the cannulated screw group and 28 patients in the short
arm cast group.
The sample size calculation for the primary outcome (2)
is based on the numbers shown in Table 3: If the sample
size in group A is 86 and the sample size in group 2 is 30,
the log-rank test for equality of survival curves with a
0.050 two-sided significance level will have a power of
approximately 92% to detect the difference between the
survival curves specified in the side table.
Data analysis
All data analysis for the primary outcomes will be done on
an intention to treat basis. As the baseline variables shown
in Table 4 are known a priori to be associated with either
of the two primary outcomes, they will be collected to
ensure we adequately control for their potential con-
founding effects. In the secondary analysis, the outcomes
will be adjusted for these confounding factors.
Discussion
When planning the study, a randomized controlled trial
was considered but as the participating surgeons, as well
as patients, often have preferences for one of the two treat-
ments under investigation, we decided to design this
study as a prospective non-randomized cohort study.
However, the design implies a potential for bias and
uncontrolled confounding, which needs to be addressed
in the method of data collection and data analysis.
Conclusion
The rationale and the design of a cohort study comparing
the time to return to daily activities in patients with non-
displaced scaphoid fractures receiving operative treatment
versus patients receiving non-operative treatment has
been presented.
Abbreviations
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Table 4: Confounding factors and variables on the outcomes
• Poverty status defined by those receiving "Low income benefit" (yes/no)
• Age




• Patients receiving additional compensation for their injury
• Occupation
• Length of pre-injury employmentBMC Musculoskeletal Disorders 2006, 7:41 http://www.biomedcentral.com/1471-2474/7/41
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